|
|
Link Between Transplanted Fatty Livers And Worse Prognosis For Patients With HCV (Medical News Today) |
|
|
|
A new study suggests that patients with hepatitis C (HCV) who need a liver transplant should not receive an organ with high levels of fatty deposits (a.k.a. hepatic steatosis). HCV recurrence was more frequent and earlier among those transplanted with such livers. These findings are in the January issue of Liver Transplantation, a journal published by John Wiley & Sons. read more |
|
|
Improving Kidneys for Transplants - 13WHAM-TV |
|
|
|
Breakthrough technology could help hundreds of patients each year in need of a kidney transplant. A study in the New England Journal of Medicine shows it ... read more |
|
After the wait of a lifetime, Layton gets his kidney (Monticello Times) |
|
|
|
Last we left Layton Schmitz, the little boy from Monticello who has chronic kidney disease, he was waiting for a transplant. The hope was that Layton, now 4 years old, would be able to get a kidney from his father, Lee. read more |
|
|
News From The Journal Of The National Cancer Institute, Jan. 13 (Medical News Today) |
|
|
|
Lapatinib Reduces Mammary Tumor Development in Mouse Model of Breast Cancer Lapatinib delayed tumor development in a mouse model of hormone receptor-negative breast cancer and reduced the number of tumors per animal compared with mice treated only with vehicle (an inert solution lacking lapatinib). read more |
|
Afinitor(R) Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More ... (Medical News Today) |
|
|
|
Data released today show Afinitor® (also known as RAD001, everolimus) halted tumor growth in 55% of patients with advanced gastric cancer, a condition for which there are limited treatment options. In addition, 45% of patients in the study demonstrated some tumor shrinkage1. read more |
|
|
|
|
<< Start < Prev 171 172 173 174 175 176 177 178 179 180 Next > End >>
|
|
Page 171 of 322 |